PDB Short entry for 2I4H HEADER HYDROLASE 21-AUG-06 2I4H TITLE STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC TITLE 2 DOMAIN CO-CRYSTALLIZED WITH A SULFAMIC ACID INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE BETA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 1662-1973; COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE BETA, R-PTP-BETA; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPRB, PTPB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TOP10; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDEST-HISMBP KEYWDS PROTEIN TYROSINE PHOSPHATASE, WPD-LOOP, SULFAMIC ACID, PHOSPHATASE, KEYWDS 2 INHIBITOR, DRUG DESIGN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.G.EVDOKIMOV,M.E.POKROSS,R.L.WALTER,M.MEKEL REVDAT 5 30-AUG-23 2I4H 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 2I4H 1 VERSN REVDAT 3 24-FEB-09 2I4H 1 VERSN REVDAT 2 24-APR-07 2I4H 1 JRNL REVDAT 1 29-AUG-06 2I4H 0 JRNL AUTH A.G.EVDOKIMOV,M.POKROSS,R.WALTER,M.MEKEL,B.COX,C.LI, JRNL AUTH 2 R.BECHARD,F.GENBAUFFE,R.ANDREWS,C.DIVEN,B.HOWARD,V.RASTOGI, JRNL AUTH 3 J.GRAY,M.MAIER,K.G.PETERS JRNL TITL ENGINEERING THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE JRNL TITL 2 PHOSPHATASE BETA FOR STRUCTURE-BASED DRUG DISCOVERY. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 1435 2006 JRNL REFN ISSN 0907-4449 JRNL PMID 17139078 JRNL DOI 10.1107/S0907444906037784 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 15799 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 791 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.19 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1019 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.51 REMARK 3 BIN R VALUE (WORKING SET) : 0.1810 REMARK 3 BIN FREE R VALUE SET COUNT : 48 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2294 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 21.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.34000 REMARK 3 B22 (A**2) : -0.40000 REMARK 3 B33 (A**2) : -0.84000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.19000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.268 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.220 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.148 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.289 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2421 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3291 ; 1.843 ; 1.956 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 289 ; 7.925 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 125 ;35.336 ;23.280 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 414 ;17.205 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;12.007 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 354 ; 0.158 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1867 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1030 ; 0.223 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1626 ; 0.315 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 161 ; 0.181 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.003 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 58 ; 0.251 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 16 ; 0.285 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): 1 ; 0.018 ; 0.200 REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1449 ; 1.632 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2301 ; 2.560 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1108 ; 4.273 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 984 ; 6.160 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1678 A 1970 REMARK 3 ORIGIN FOR THE GROUP (A): 27.9540 0.3340 16.1710 REMARK 3 T TENSOR REMARK 3 T11: -0.0293 T22: -0.0304 REMARK 3 T33: -0.0346 T12: 0.0004 REMARK 3 T13: 0.0091 T23: -0.0025 REMARK 3 L TENSOR REMARK 3 L11: 0.3255 L22: 0.2793 REMARK 3 L33: 0.3610 L12: 0.0446 REMARK 3 L13: 0.1781 L23: -0.0405 REMARK 3 S TENSOR REMARK 3 S11: 0.0006 S12: -0.0015 S13: 0.0089 REMARK 3 S21: 0.0232 S22: -0.0374 S23: 0.0053 REMARK 3 S31: 0.0020 S32: -0.0053 S33: 0.0367 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ONE TLS GROUP FOR WHOLE PROTEIN CHAIN REMARK 4 REMARK 4 2I4H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039125. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : SI MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15799 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 27.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.4800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.18700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.260 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2HC1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 8000, 220 MM MGCL2, 80 MM REMARK 280 NH4OAC, 1% BME, 0.1% BOG, 5MM DTT, PH 8.1, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.65650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.39750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.65650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.39750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 MG MG A 202 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 60 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 61 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1661 REMARK 465 ASP A 1662 REMARK 465 ARG A 1663 REMARK 465 PRO A 1664 REMARK 465 LEU A 1665 REMARK 465 SER A 1666 REMARK 465 VAL A 1667 REMARK 465 HIS A 1668 REMARK 465 LEU A 1669 REMARK 465 ASN A 1670 REMARK 465 LEU A 1671 REMARK 465 GLY A 1672 REMARK 465 GLN A 1673 REMARK 465 LYS A 1674 REMARK 465 GLY A 1675 REMARK 465 ASN A 1676 REMARK 465 ARG A 1677 REMARK 465 ASN A 1748 REMARK 465 VAL A 1749 REMARK 465 ASP A 1750 REMARK 465 ASP A 1751 REMARK 465 ASP A 1752 REMARK 465 PRO A 1753 REMARK 465 GLY A 1850 REMARK 465 GLU A 1851 REMARK 465 GLU A 1852 REMARK 465 GLN A 1853 REMARK 465 LEU A 1854 REMARK 465 ASP A 1855 REMARK 465 ALA A 1856 REMARK 465 SER A 1971 REMARK 465 GLU A 1972 REMARK 465 GLN A 1973 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A1967 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 93 O HOH A 193 2.04 REMARK 500 O HOH A 29 O HOH A 77 2.15 REMARK 500 O HOH A 92 O HOH A 196 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG A 1861 OD1 ASP A 1928 4555 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A1848 CB - CA - C ANGL. DEV. = -12.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1716 2.22 -60.56 REMARK 500 ASN A1716 8.60 -66.23 REMARK 500 ASP A1819 -161.21 -164.71 REMARK 500 HIS A1871 -1.28 69.14 REMARK 500 ASN A1892 -8.25 -59.96 REMARK 500 CYS A1904 -121.34 -128.16 REMARK 500 SER A1905 -60.02 -95.87 REMARK 500 VAL A1908 -51.12 -136.09 REMARK 500 VAL A1947 86.76 69.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 58 O REMARK 620 2 HOH A 58 O 171.4 REMARK 620 3 HOH A 59 O 93.4 85.9 REMARK 620 4 HOH A 59 O 85.7 93.9 173.2 REMARK 620 5 HOH A 60 O 94.2 94.4 93.3 93.5 REMARK 620 6 HOH A 60 O 94.0 94.6 93.4 93.4 0.2 REMARK 620 7 HOH A 61 O 85.1 86.2 87.0 86.2 179.3 179.1 REMARK 620 8 HOH A 61 O 85.9 85.5 86.1 87.1 179.4 179.5 1.1 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UA1 A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I3U RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC REMARK 900 DOMAIN IN COMPLEX WITH INHIBITORS REMARK 900 RELATED ID: 2I3R RELATED DB: PDB REMARK 900 ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA REMARK 900 RELATED ID: 2I4G RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC REMARK 900 DOMAIN IN COMPLEX WITH A SULFAMIC ACID (SOAKING EXPERIMENT REMARK 900 RELATED ID: 2I4E RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC REMARK 900 DOMAIN CO-CRYSTALLIZED WITH A SULFAMIC ACID INHIBITOR DBREF 2I4H A 1662 1973 UNP P23467 PTPRB_HUMAN 1662 1973 SEQADV 2I4H SER A 1661 UNP P23467 CLONING ARTIFACT SEQRES 1 A 313 SER ASP ARG PRO LEU SER VAL HIS LEU ASN LEU GLY GLN SEQRES 2 A 313 LYS GLY ASN ARG LYS THR SER CYS PRO ILE LYS ILE ASN SEQRES 3 A 313 GLN PHE GLU GLY HIS PHE MET LYS LEU GLN ALA ASP SER SEQRES 4 A 313 ASN TYR LEU LEU SER LYS GLU TYR GLU GLU LEU LYS ASP SEQRES 5 A 313 VAL GLY ARG ASN GLN SER CYS ASP ILE ALA LEU LEU PRO SEQRES 6 A 313 GLU ASN ARG GLY LYS ASN ARG TYR ASN ASN ILE LEU PRO SEQRES 7 A 313 TYR ASP ALA THR ARG VAL LYS LEU SER ASN VAL ASP ASP SEQRES 8 A 313 ASP PRO CYS SER ASP TYR ILE ASN ALA SER TYR ILE PRO SEQRES 9 A 313 GLY ASN ASN PHE ARG ARG GLU TYR ILE VAL THR GLN GLY SEQRES 10 A 313 PRO LEU PRO GLY THR LYS ASP ASP PHE TRP LYS MET VAL SEQRES 11 A 313 TRP GLU GLN ASN VAL HIS ASN ILE VAL MET VAL THR GLN SEQRES 12 A 313 CYS VAL GLU LYS GLY ARG VAL LYS CYS ASP HIS TYR TRP SEQRES 13 A 313 PRO ALA ASP GLN ASP SER LEU TYR TYR GLY ASP LEU ILE SEQRES 14 A 313 LEU GLN MET LEU SER GLU SER VAL LEU PRO GLU TRP THR SEQRES 15 A 313 ILE ARG GLU PHE LYS ILE CYS GLY GLU GLU GLN LEU ASP SEQRES 16 A 313 ALA HIS ARG LEU ILE ARG HIS PHE HIS TYR THR VAL TRP SEQRES 17 A 313 PRO ASP HIS GLY VAL PRO GLU THR THR GLN SER LEU ILE SEQRES 18 A 313 GLN PHE VAL ARG THR VAL ARG ASP TYR ILE ASN ARG SER SEQRES 19 A 313 PRO GLY ALA GLY PRO THR VAL VAL HIS CYS SER ALA GLY SEQRES 20 A 313 VAL GLY ARG THR GLY THR PHE ILE ALA LEU ASP ARG ILE SEQRES 21 A 313 LEU GLN GLN LEU ASP SER LYS ASP SER VAL ASP ILE TYR SEQRES 22 A 313 GLY ALA VAL HIS ASP LEU ARG LEU HIS ARG VAL HIS MET SEQRES 23 A 313 VAL GLN THR GLU CYS GLN TYR VAL TYR LEU HIS GLN CYS SEQRES 24 A 313 VAL ARG ASP VAL LEU ARG ALA ARG LYS LEU ARG SER GLU SEQRES 25 A 313 GLN HET MG A 202 1 HET CL A 203 1 HET UA1 A 401 37 HETNAM MG MAGNESIUM ION HETNAM CL CHLORIDE ION HETNAM UA1 N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4- HETNAM 2 UA1 (SULFOAMINO)-L-PHENYLALANINAMIDE FORMUL 2 MG MG 2+ FORMUL 3 CL CL 1- FORMUL 4 UA1 C24 H32 N4 O8 S FORMUL 5 HOH *182(H2 O) HELIX 1 1 ILE A 1685 LEU A 1710 1 26 HELIX 2 2 LEU A 1724 ASN A 1731 5 8 HELIX 3 3 TYR A 1739 ALA A 1741 5 3 HELIX 4 4 THR A 1782 GLN A 1793 1 12 HELIX 5 5 THR A 1876 ASN A 1892 1 17 HELIX 6 6 VAL A 1908 LYS A 1927 1 20 HELIX 7 7 ASP A 1931 LEU A 1941 1 11 HELIX 8 8 THR A 1949 ARG A 1967 1 19 SHEET 1 A 2 ILE A1683 LYS A1684 0 SHEET 2 A 2 SER A1929 VAL A1930 -1 O VAL A1930 N ILE A1683 SHEET 1 B 9 ARG A1743 LYS A1745 0 SHEET 2 B 9 TYR A1757 ILE A1763 -1 O ALA A1760 N VAL A1744 SHEET 3 B 9 TYR A1772 THR A1775 -1 O VAL A1774 N SER A1761 SHEET 4 B 9 THR A1900 HIS A1903 1 O THR A1900 N ILE A1773 SHEET 5 B 9 ASN A1797 MET A1800 1 N VAL A1799 O VAL A1901 SHEET 6 B 9 ARG A1858 TYR A1865 1 O PHE A1863 N ILE A1798 SHEET 7 B 9 TRP A1841 CYS A1849 -1 N THR A1842 O HIS A1864 SHEET 8 B 9 LEU A1828 VAL A1837 -1 N SER A1836 O ILE A1843 SHEET 9 B 9 LEU A1823 TYR A1825 -1 N TYR A1825 O LEU A1828 SHEET 1 C 2 VAL A1805 GLU A1806 0 SHEET 2 C 2 ARG A1809 VAL A1810 -1 O ARG A1809 N GLU A1806 LINK O HOH A 58 MG MG A 202 1555 1555 1.99 LINK O HOH A 58 MG MG A 202 2656 1555 1.97 LINK O HOH A 59 MG MG A 202 1555 1555 2.02 LINK O HOH A 59 MG MG A 202 2656 1555 2.02 LINK O HOH A 60 MG MG A 202 1555 1555 2.03 LINK O HOH A 60 MG MG A 202 2656 1555 2.03 LINK O HOH A 61 MG MG A 202 1555 1555 1.98 LINK O HOH A 61 MG MG A 202 2656 1555 1.98 SITE 1 AC1 4 HOH A 58 HOH A 59 HOH A 60 HOH A 61 SITE 1 AC2 4 GLY A1765 ASN A1767 PHE A1768 ARG A1970 SITE 1 AC3 20 HOH A 125 ARG A1715 ASN A1716 SER A1718 SITE 2 AC3 20 ASP A1720 ARG A1732 TYR A1733 ASN A1734 SITE 3 AC3 20 ASN A1735 LYS A1807 GLY A1808 ASP A1870 SITE 4 AC3 20 HIS A1871 CYS A1904 SER A1905 ALA A1906 SITE 5 AC3 20 GLY A1907 VAL A1908 GLY A1909 ARG A1910 CRYST1 113.313 38.795 66.983 90.00 104.94 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008825 0.000000 0.002355 0.00000 SCALE2 0.000000 0.025777 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015451 0.00000